Development of building projects
DIONE AS
Revenue 2024
NOK 50,000
Operating profit
NOK −161,000
Equity
NOK 51.6m
Incorporated
1993
Share capital
NOK 1.1m
Roles
Regnskapsfører
Revisor
Styrets lederJacob Andreas Møller
VaramedlemNiels Christian Møller
Auditor
Audit firm
ERNST & YOUNG AS
ERNST & YOUNG AS har 238 registrerte statsautoriserte revisorer.
The Brønnøysund registers name the audit firm, not which individual auditor signs the accounts.
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| ELJACH INVEST AS | 98.9% | 1108000.000000 | 2025 |
| ELJACH INVEST AS | 1.1% | 12000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| DRANGEDALSVEIEN 102 AS | Active | 100.0% | 1000.000000 |
| DIONE EIENDOM AS | Active | 98.9% | 1108000.000000 |
| DOKKVEGEN UTVIKLING AS | Active | 50.0% | 15000.000000 |
| NORDIC PORTO AS | In liquidation | 7.5% | 30750.000000 |
| LOKHOLMEN AS | Active | 4.4% | 31000.000000 |
| BORGESTAD ASA | Active | 3.1% | 1097137.000000 |
| AI BUSINESS LAB AS | Active | 2.0% | 245000.000000 |
| ALLIANCE CHEMTANKERS AS | Active | 2.0% | 23800.000000 |
| DIONE EIENDOM AS | Active | 1.1% | 12000.000000 |
| KECHU MIDCO AS | Active | 0.5% | 2940772.000000 |
| BIOMOLEX AS | Active | 0.1% | 912.000000 |
| KECHU MIDCO AS | Active | 0.0% | 172435.000000 |
| NEXTERA AS | Active | 0.0% | 900.000000 |
| NYKODE THERAPEUTICS ASA | Active | 0.0% | 38000.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.